The inhibitory effect of curcumin on airway inflammation in mice with chronic obstructive pulmonary disease and its mechanism: a study based on the PPARγ/AMPK/mTORC1 pathway
Cytotechnology · 2026-08 · 78 (4)
DOI: 10.1007/s10616-026-01002-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytotechnology, online erschienen am 26.06.2026. Verfasst von Mengjuan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Lequn Branch, The First Affiliated Hospital of Jilin University, No. 3302, Jilin Road, Intersection of Jilin Road…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Jilin Province Science and Technology Development Program Project.
Themen: COPD
Abstract (Originalsprache)
In this article, we explored the mechanism of curcumin (CUR) in mitigating airway inflammation in a mouse model of chronic obstructive pulmonary disease (COPD) based on the peroxisome proliferator-activated receptor γ (PPARγ)/adenosine monophosphate-activated protein kinase (AMPK)/mammalian target of rapamycin complex 1 (mTORC1) pathway. A COPD mouse model was established via smoke exposure & intratracheal instillation of lipopolysaccharide. Mice were administered the CUR, the PPARγ knockdown adeno-associated virus, or the PPARγ inhibitor GW9662. Bronchoalveolar lavage fluid (BALF) was collected, and the lung wet-to-dry (W/D) weight ratio was measured. Inflammatory cell counts and inflammatory factors in BALF were assessed by a hemocytometer and ELISA. The binding pattern between CUR and PPARγ was analyzed by molecular docking and further verified by drug affinity responsive target stability assay, and pulmonary PPARγ, p-AMPK/AMPK, and p-mTOR/mTOR levels were detected by western blot assay. COPD mice showed elevated lung tissue W/D ratio, BALF interleukin-8, tumor necrosis factor α levels, and white blood cell, lymphocyte, and neutrophil counts, with prominent inflammatory cell infiltration, thickened alveolar wall, and noticeable pulmonary interstitial edema and congestion. Importantly, CUR treatment significantly ameliorated these changes. CUR upregulated PPARγ by directly binding to PPARγ with strong binding affinity, enhanced AMPK phosphorylation, and suppressed mTOR activity. In contrast, PPARγ knockdown or inhibition reduced p-AMPK, increased p-mTOR, aggravated inflammation and lung damage, and partially reversed the beneficial effects of CUR. CUR directly binds to PPARγ to activate AMPK to inhibit mTORC1 activity, thereby ameliorating airway inflammation in COPD mice. Supplementary Information: The online version contains supplementary material available at 10.1007/s10616-026-01002-x.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Lequn Branch, The First Affiliated Hospital of Jilin University, No. 3302, Jilin Road, Intersection of Jilin Road and Lequn Street, Changchun, 130031 Jilin Province China.
- Department of Respiratory Medicine, The First Affiliated Hospital of Jilin University, 130000, Changchun, China.
Förderung
- Jilin Province Science and Technology Development Program Project
Zitieren
APA
Wang, M., Zhang, K., Zhang, Y., Gu, Y., & Liu, C. (2026). The inhibitory effect of curcumin on airway inflammation in mice with chronic obstructive pulmonary disease and its mechanism: a study based on the PPARγ/AMPK/mTORC1 pathway. Cytotechnology, 78(4). https://doi.org/10.1007/s10616-026-01002-x
Vancouver
Wang M, Zhang K, Zhang Y, Gu Y, Liu C. The inhibitory effect of curcumin on airway inflammation in mice with chronic obstructive pulmonary disease and its mechanism: a study based on the PPARγ/AMPK/mTORC1 pathway. Cytotechnology. 2026;78(4). doi:10.1007/s10616-026-01002-x
BibTeX
@article{Wang2026,
author = {Wang, Mengjuan and Zhang, Kaifeng and Zhang, Yujia and Gu, Yue and Liu, Chaoying},
title = {The inhibitory effect of curcumin on airway inflammation in mice with chronic obstructive pulmonary disease and its mechanism: a study based on the PPARγ/AMPK/mTORC1 pathway},
journal = {Cytotechnology},
year = {2026},
volume = {78},
number = {4},
doi = {10.1007/s10616-026-01002-x}
}
EUVIMED